The positive impact that generic and biosimilar medicines have on patients and health systems (October 2019)
The positive impact that generic and biosimilar medicines have on patients and health systems (October 2019)
The positive impact that generic and biosimilar medicines have on patients and health systems (October 2019)
IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION
C/O DYN SA
Rue de Cornavin 11
1201 Geneva, Switzerland
E-mails:
This email address is being protected from spambots. You need JavaScript enabled to view it.
or
Secretary General –
This email address is being protected from spambots. You need JavaScript enabled to view it.